Table 3 Trial outcomes in Routine F/U patients
From: Attrition in longitudinal randomized controlled trials: home visits make a difference
CARDIAC AND NEUROLOGIC MORBIDITY AND MORTALITY (N=192) | P | # OF COMPLICATIONS | ||
|---|---|---|---|---|
Low MAP (n=101) | 15.8% | Perioperative | 13 | |
6 months | 4 | |||
Total | 17 | |||
0.022 | ||||
High MAP (n=91) | 5.5% | Perioperative | 4 | |
6 months | 3 | |||
Total | 5 | |||
Total Cardiac and neurologic morbidity and mortality | 10.9% | Total | 21 | |
Neurocognitive Dysfunction Cardiac and Neurologic Morbidity and Mortality at 6 months (n=166) | ||||
Low MAP | 11.6% | 0.68 | 6 months | 10 |
High MAP | 13.8% | 6 months | 11 | |
Total | 12.7% | 21 | ||
Functional Decline at 6 months n=160) | ||||
Low MAP | 9.4% | 0.38 | 6 months | 8 |
High MAP | 5.3% | 6 months | 4 | |
Total | 7.5% | 12 | ||
Combined Trial Outcome (n=192) | ||||
Low MAP | 31.7% | 0.061 | 32 | |
High MAP | 19.8% | 18 | ||
Total | 26.0% | 50 | ||